Research Article

Molecular Imaging and Biology

, Volume 10, Issue 4, pp 182-191

Genome-free Viral Capsids as Carriers for Positron Emission Tomography Radiolabels

  • Jacob M. HookerAffiliated withDepartment of Chemistry, University of California
  • , James P. O’NeilAffiliated withDepartment of Molecular Imaging and Neuroscience, Lawrence Berkeley National Laboratory
  • , Dante W. RomaniniAffiliated withDepartment of Chemistry, University of California
  • , Scott E. TaylorAffiliated withDepartment of Molecular Imaging and Neuroscience, Lawrence Berkeley National Laboratory
  • , Matthew B. FrancisAffiliated withDepartment of Chemistry, University of CaliforniaMaterials Sciences Division, Lawrence Berkeley National Labs Email author 

Rent the article at a discount

Rent now

* Final gross prices may vary according to local VAT.

Get Access

Abstract

Purpose

We have developed a modular synthetic strategy to append imaging agents to a viral capsid.

Procedures

The hollow protein shell of bacteriophage MS2 (mtMS2) was labeled on its inside surface with [18F]fluorobenzaldehyde through a multistep bioconjugation strategy. An aldehyde functional group was first attached to interior tyrosine residues through a diazonium coupling reaction. The aldehyde was further elaborated to an alkoxyamine functional group, which was then condensed with n.c.a. [18F]fluorobenzaldehyde. Biodistribution of the radioactive MS2 conjugates was subsequently evaluated in Sprague–Dawley rats.

Results

Relative to fluorobenzaldehyde, fluorine-18-labeled MS2 exhibited prolonged blood circulation time and a significantly altered excretion profile. It was also observed that additional small molecule cargo installed inside the capsids did not alter the biodistribution.

Conclusions

These studies provide further insight into the pharmacokinetic behavior of nanomaterials and serve as a platform for the future development of targeted imaging and therapeutic agents based on mtMS2.

Key words

Virus PET Oxime Bioconjugation F-18